India administers 80 lakh HPV vaccine doses to prevent cervical cancer

India has administered 80 lakh doses of HPV vaccine, marking a significant milestone in its cervical cancer prevention efforts. The vaccine protects against human papillomavirus, which is the primary cause of cervical cancer.

This large-scale immunization drive reflects the government's commitment to public health and disease prevention among women.